Abstract

CD44 is a receptor for the matrix glycosaminoglycan hyaluronan. Proteoglycan forms of CD44 also exhibit affinity for fibronectin and collagen as well as chemokines and growth factors. CD44 plays a role in autoimmunity, inflammation, and tumor progression. Soluble CD44 (sCD44) is found in plasma, and the levels of sCD44 correlate with immune function and some malignancies. The mechanisms by which sCD44 is generated and its function are unknown. We demonstrate here that normal bronchial epithelial cells spontaneously release sCD44. Exposure to phagocyte- and bacterium-derived proteinases markedly increased the release of sCD44 from epithelial cells. The spontaneously released sCD44 was incorporated into high molecular mass complexes derived from the matrix that also contained chondroitin sulfate, fibronectin, hyaluronan, and collagens I and IV. Enzymatic digestion with proteinases liberated sCD44 from the high molecular mass complex. Consistent with the homology of CD44 to proteoglycan core and link proteins, these data suggest that CD44 spontaneously released from normal bronchial epithelial cells can accumulate as an integral component of the matrix, where it may play a role in the organization of matrices and in anchoring growth factors and chemokines to the matrix. Increases in plasma CD44 during immune activation and tumor progression therefore may be a manifestation of the matrix remodeling that occurs in the face of the enhanced proteolytic activity associated with infection, inflammation, and tumor metastasis, leading to alterations in cell-matrix interactions.

Highlights

  • CD44 is a receptor for the matrix glycosaminoglycan hyaluronan

  • Consistent with the homology of CD44 to proteoglycan core and link proteins, these data suggest that CD44 spontaneously released from normal bronchial epithelial cells can accumulate as an integral component of the matrix, where it may play a role in the organization of matrices and in anchoring growth factors and chemokines to the matrix

  • Our results suggest that CD44 released from epithelial cells may accumulate as an integral component of the HA-binding protein; Enzyme-linked Immunosorbent Assay (ELISA), enzyme-linked immunosorbent assay; ICAM-1, intercellular adhesion molecule-1; GAG, glycosaminoglycan; CatG, cathepsin G

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—The following anti-human CD44 monoclonal antibodies were used (2): 5F12 To determine the level of HA associated with the cell surface, NBEC were stained with biotinylated bovine HA-binding protein (bPG), followed by PE-conjugated streptavidin. To detect matrix components physically associated with sCD44, conditioned media were incubated on streptavidin plates (Pierce) coated with biotinylated HA-binding protein or biotinylated anti-type I or anti-type IV collagen antibody to capture HA. To determine the HA content in cell lysates and conditioned media, we developed a modified ELISA based on competitive binding of endogenous HA and FITC-labeled exogenous HA to microwell-bound bPG. Unsaturated bPG sites were detected by incubation with FITC-HA at 37 °C for 30 min, followed by incubation with alkaline phosphatase-conjugated anti-FITC mAb and p-nitrophenyl phosphate

RESULTS
Control CatG SAMP PAMP
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call